These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18844587)

  • 21. Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51.
    Schuller E; Klade CS; Heinz FX; Kollaritsch H; Rendi-Wagner P; Jilma B; Tauber E
    Vaccine; 2008 Nov; 26(48):6151-6. PubMed ID: 18804132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WHO prequalifies Chinese-produced Japanese encephalitis vaccine.
    Riedmann EM
    Hum Vaccin Immunother; 2013 Dec; 9(12):2500-1. PubMed ID: 24716206
    [No Abstract]   [Full Text] [Related]  

  • 23. Expert opinion on vaccination of travelers against Japanese encephalitis.
    Burchard GD; Caumes E; Connor BA; Freedman DO; Jelinek T; Jong EC; von Sonnenburg F; Steffen R; Tsai TF; Wilder-Smith A; Zuckerman J
    J Travel Med; 2009; 16(3):204-16. PubMed ID: 19538583
    [No Abstract]   [Full Text] [Related]  

  • 24. [Development of new Japanese encephalitis vaccine].
    Ishikawa T
    Nihon Rinsho; 2005 Dec; 63(12):2133-7. PubMed ID: 16363685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statement on protection against Japanese encephalitis. An Advisory Committee Statement (ACS).
    Committee to Advise on Tropical Medicine and Travel (CATMAT)
    Can Commun Dis Rep; 2008 Sep; 34(ACS-4):1-14. PubMed ID: 18841582
    [No Abstract]   [Full Text] [Related]  

  • 26. [Efficacy of a single dose of a vaccine (SA14-14-2) against Japanese encephalitis].
    Diagana M; Ngoungou EB; Preux PM
    Med Trop (Mars); 2006 Apr; 66(2):205. PubMed ID: 16775949
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunization against Japanese encephalitis in China: a policy analysis.
    Liu W; Clemens JD; Yang JY; Xu ZY
    Vaccine; 2006 Jun; 24(24):5178-82. PubMed ID: 16697091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
    Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H
    J Gene Med; 2009 Feb; 11(2):150-9. PubMed ID: 19040206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Japanese encephalitis vaccine.
    Dubey AP;
    Indian Pediatr; 2000 Oct; 37(10):1083-4. PubMed ID: 11042706
    [No Abstract]   [Full Text] [Related]  

  • 30. Editorial commentary: Boosting Japanese encephalitis vaccine.
    Hatz C
    Clin Infect Dis; 2012 Sep; 55(6):835-6. PubMed ID: 22696016
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of murine bone marrow-derived dendritic cells loaded with inactivated virus as a vaccine against Japanese encephalitis virus.
    Li Y; Xu M; Chen L; Zhu J; Ye J; Liu X; Sun Y; Chen H; Cao S
    Vaccine; 2009 Oct; 27(43):6004-10. PubMed ID: 19665607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Japanese encephalitis virus DNA vaccine candidates in rhesus monkeys [Macaca mulatta].
    Bharati K; Rani R; Vrati S
    Vaccine; 2009 Jan; 27(1):10-6. PubMed ID: 18996161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination against Japanese encephalitis with IC51: systematic review on immunogenicity, duration of protection and safety.
    Kling K; Harder T; Younger Z; Burchard G; Schmidt-Chanasit J; Wichmann O
    J Travel Med; 2020 Mar; 27(2):. PubMed ID: 32043122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucosal vaccination approach against mosquito-borne Japanese encephalitis virus.
    Harakuni T; Kohama H; Tadano M; Uechi G; Tsuji N; Matsumoto Y; Miyata T; Tsuboi T; Oku H; Arakawa T
    Jpn J Infect Dis; 2009 Jan; 62(1):37-45. PubMed ID: 19168957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [An unusual cause of meningo-encephalitis: Japanese encephalitis].
    Delsing CE; Ardesch J; Nihom J; Mulder L; Kootstra GJ; Hylkema BS
    Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2423-7. PubMed ID: 16277134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A strategic plan for Japanese encephalitis control by 2015.
    Elias C; Okwo-Bele JM; Fischer M
    Lancet Infect Dis; 2009 Jan; 9(1):7. PubMed ID: 19095192
    [No Abstract]   [Full Text] [Related]  

  • 37. Japanese encephalitis vaccine for travelers: risk-benefit reconsidered.
    Connor BA; Hamer DH; Kozarsky P; Jong E; Halstead SB; Keystone J; Mileno MD; Dawood R; Rogers B; Bunn WB
    J Travel Med; 2019 Jun; 26(5):. PubMed ID: 31073616
    [No Abstract]   [Full Text] [Related]  

  • 38. Japanese encephalitis in travelers: review of cases and seasonal risk.
    Buhl MR; Lindquist L
    J Travel Med; 2009; 16(3):217-9. PubMed ID: 19538584
    [No Abstract]   [Full Text] [Related]  

  • 39. Japanese Encephalitis Among Three U.S. Travelers Returning from Asia, 2003-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Jul; 58(27):737-40. PubMed ID: 19609246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WHO informal consultation on the scientific basis of specifications for production and control of inactivated Japanese encephalitis vaccines for human use, Geneva, Switzerland, 1-2 June 2006.
    Ferguson M; Kurane I; Wimalaratne O; Shin J; Wood D;
    Vaccine; 2007 Jul; 25(29):5233-43. PubMed ID: 17590244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.